Other languages Design Therapeutics, Inc.

Equities

DSGN

US25056L1035

Real-time Estimate Cboe BZX Other stock markets 12:47:50 27/06/2024 am IST			5-day change	1st Jan Change
3.225 ^USD	-2.57%		-2.72%	+21.51%

17/06	Design Therapeutics, Inc. Elects Pratik Shah, Ph.D. as Class III Director	CI
08/05	Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Design Therapeutics, Inc. Elects Pratik Shah, Ph.D. as Class III Director	18/06
Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Sector Update: Health Care Stocks Ease Late Afternoon	21/03
Sector Update: Health Care Stocks Down Wednesday Afternoon	20/03
Design Therapeutics Stock Rises as RBC Says Q4 Results, Product Candidate Updates Show Progress	20/03
Design Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
Design Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	20/03
Design Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Insider Buy: Design Therapeutics	31/23/31
Design Therapeutics, Inc. Announces CEO Changes	26/23/26
Design Therapeutics, Inc. Announces Management Changes	26/23/26
Financial Sector Woes, Lackluster Chinese Data Weigh on US Equity Markets	15/23/15
Sector Update: Health Care Stocks Slip Pre-Bell Tuesday	15/23/15
Sentiment Subdued After Downbeat China Data, Pushing US Equity Futures Lower Pre-Bell	15/23/15
Sector Update: Health Care	15/23/15
Top Premarket Decliners	15/23/15
Design Therapeutics Reports DT-216 Well-Tolerated in Phase 1 Trial But Injection Site Reactions Observed	15/23/15
Design Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15
Design Therapeutics, Inc. Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia	15/23/15
Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	10/23/10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Design Therapeutics, Inc.

Equities

DSGN

US25056L1035

Other languages

Filters